Arcellx, Inc. (ACLX)

64.13 -2.40 (-3.61%) USD  |  NASDAQ  |  Feb 20, 16:00
63.20 -0.93 (-1.45%) After-Hours: 19:51
More

Arcellx Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Amicus Therapeutics, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade